Bobby L Boyanton

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Multidrug Resistant

Antimicrobial Resistance

Respiratory Syndrome Coronavirus

Top Venues

Microbiology spectrum

Clinical pediatrics

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Bobby L Boyanton, Rachel A Frenner, Ashton Ingold, Lilliam Ambroggio, Joshua L Kennedy
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to Mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas. Microbiology spectrum 12 (4) (2024)
Bobby L Boyanton, Rachel A Frenner, Ashton Ingold, Lilliam Ambroggio, Joshua L Kennedy
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to Mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas. Microbiology spectrum 12 (4) (2024)
Bobby L Boyanton, Rachel A Frenner, Ashton Ingold, Lilliam Ambroggio, Joshua L Kennedy
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to Mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas. Microbiology spectrum (2024)
Bobby L Boyanton, Rachel A Frenner, Ashton Ingold, Lilliam Ambroggio, Joshua L Kennedy
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to Mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas. Microbiology spectrum 12 (4) (2024)
Bobby L Boyanton, Rachel A Frenner, Ashton Ingold, Lilliam Ambroggio, Joshua L Kennedy
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to Mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas. Microbiology spectrum 12 (4) (2024)
Bobby L Boyanton, Rachel A Frenner, Ashton Ingold, Lilliam Ambroggio, Joshua L Kennedy
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to Mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas. Microbiology spectrum (2024)
Bobby L Boyanton, Rachel A Frenner, Ashton Ingold, Lilliam Ambroggio, Joshua L Kennedy
SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to Mycoplasma pneumoniae and Co-Infecting Respiratory Viruses in Arkansas. medRxiv : the preprint server for health sciences (2023)
Bobby L Boyanton, Jessica N Snowden, Rachel A Frenner, Eric R Rosenbaum, Heather L Young, Joshua L Kennedy
SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis. Clinical pediatrics (2022)
Bobby L Boyanton, Jessica N Snowden, Rachel A Frenner, Eric R Rosenbaum, Heather L Young, Joshua L Kennedy
SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis. Clinical pediatrics (2022)
Bobby L Boyanton, Jessica N Snowden, Rachel A Frenner, Eric R Rosenbaum, Heather L Young, Joshua L Kennedy
SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis. Clinical pediatrics (2022)